MetaReal Corporation
6182・Growth Market・Services
Business
Metareal Corporation is a holding company operating three businesses: the "AI Business" (core subsidiary: Rozetta Corporation), which provides AI-based machine translation and generative AI services; the "HT Business" (Grovar Inc.), covering human translation, interpretation, and language education; and the "Metaverse Business" (MATRIX, Inc. and STUDIO55, Inc.), covering VR, metaverse, and digital twin solutions. Listed on the TSE Growth Market in 2015. The company provides industry-specific AI solutions for sectors such as pharmaceuticals, manufacturing, legal, and finance to a customer base of over 6,000 companies, positioning itself around "industry-specific × vertically integrated AI agents × global support for Japanese companies." Its corporate mission is "liberating humanity from the constraints of place, time, language, and physicality."
Business Model
A three-layer structure positions the HT Business (revenue of ¥709 million, profit margin of 17.6%) as the cash cow, the AI Business (revenue of ¥2,823 million) as the short-to-medium-term growth engine, and the Metaverse Business as the long-term investment. In the AI Business, in addition to stable revenue from SaaS-type machine translation such as T-4OO, the company aims to increase added value through industry-specific Vertical SaaS and contract development, including RakuYaku AI for the pharmaceutical industry and Shikiho AI for the financial industry. Revenue mainly consists of subscriptions, contract development, and licensing.
Company Strengths
As a leading AI translation company, the Group has built a customer base of over 6,000 companies through more than 20 years of business operations. Its customer group, specialized in fields such as pharmaceuticals, manufacturing, legal affairs, patents, and finance, functions as a cross-selling foundation for vertically integrated AI agents, enabling a shift to high-value-added services while suppressing new customer acquisition costs.
In FY2025 (ended February 2025), the Group invested ¥248 million in R&D expenses, developing and launching multiple industry-specific AI products, including RakuYaku for the pharmaceutical industry, Shikiho AI and Metareal DD for the financial industry, Koho AI for public relations, and a generative AI-enabled prototype of T-4OO. Of the total capital expenditure of ¥344 million, ¥248 million was allocated to servers and other infrastructure for the AI Business, strengthening the technology base.
In December 2024, the Group made STUDIO55 Inc. (55% equity interest), which possesses advanced specialized skills and a broad customer base in the VR, CG & BIM field of architectural design, a subsidiary. By combining the Group's cutting-edge AI technologies, such as Gaussian Splatting, with STUDIO55's expertise and customer base in the architecture industry, the Group has established a platform for deploying digital twin auto-generation AI solutions.
ENVALITH's Perspective
Performance Trend
Revenue over the past five fiscal years has been flat, ranging between ¥4,085 million and ¥4,487 million. In the first quarter of FY2027 (ending February 2027), revenue continued to decline, coming in at ¥995 million (down 11.5% year on year), mainly due to a decrease in orders received in the AI Business (down 31.0% year on year). On the other hand, operating loss improved to ¥35 million from ¥61 million in the same period of the previous year, reflecting the emerging effects of SG&A cost reductions (down ¥130 million year on year). The full-year forecast anticipates a turnaround to profitability, with revenue of ¥4,600 million and operating income of ¥330 million, but the progress rate in the first quarter was low, and recovery in orders in the second half through the SaS/FDE transition is a prerequisite for achieving this forecast. It should be recognized as a structural headwind that changes in the external environment—namely, the rapid evolution of generative AI—are putting pressure on demand for the existing SaaS model.
Growth Strategy
Shift toward SaS/FDE model with focused investment in two high-growth segments, and recovery of profitability through M&A-driven acquisition of specialized customer bases
With the "Ultra High-Precision" mode released in April 2026, word usage among core-needs customers has begun to increase, and the company is advancing deployment to translation companies and translators along with a shift to SaS (a model providing completed-work outcomes). The aim is to achieve a productivity revolution through the full automation of industrial translation.
By combining STUDIO55's specialized know-how in the construction field with Rozetta's AI technology, the company is advancing the AI-enabled transformation of customer-specific plugin development processes in an FDE-driven manner. The goal is business growth through reduced outsourcing man-hours, shorter delivery times, and an increased number of manageable projects. The AI/MV Marketing Business turned profitable in Q1.
Organizational restructuring targeting Metareal and Rozetta was implemented effective July 1, 2026. Through the automation and acceleration of internal operations by task-execution AI, the company is shifting to a structure in which employees focus on decision-making and customer value creation. The effect of reduced SG&A expenses was already evident in Q1.
To accelerate growth in each agentic AI domain—Fully Automatic Translation AI, construction-specialized, pharmaceutical-specialized, and business creation—the company is pursuing M&A targeting companies engaged in specialized document and design work. The policy is to improve gross margins through early post-acquisition transition to SaS.
As a mid-term strategy, this is a development business aimed at resolving inefficiencies in document creation within the pharmaceutical industry and contributing to accelerating the speed of new drug approvals. At present it remains in a long-term investment phase, with concrete revenue contribution expected only in the future.
Last updated: July 17, 2026